Back
Labcorp Holdings 10K Form
Sell
42
LH
Labcorp Holdings
Last Price:
240.11
Seasonality Move:
4.92%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-30 | 10Q | LH/Labcorp Holdings Quarterly |
| 2024-02-26 | 10K | LH/Labcorp Holdings Annual |
| 2023-10-30 | 10Q | LH/Labcorp Holdings Quarterly |
| 2023-08-04 | 10Q | LH/Labcorp Holdings Quarterly |
| 2023-05-04 | 10Q | LH/Labcorp Holdings Quarterly |
| 2023-02-28 | 10K | LH/Labcorp Holdings Annual |
Receive LH News And Ratings
See the #1 stock for the next 7 days that we like better than LH
LH Financial Statistics
Sales & Book Value
| Annual Sales: | $12.16B |
|---|---|
| Cash Flow: | $161.5M |
| Price / Cash Flow: | 23.98 |
| Annual Sales: | $97.61 |
| Price / Book: | 2.44 |
Profitability
| EPS (TTM): | 5.15000 |
|---|---|
| Net Income (TTM): | $435.5M |
| Gross Margin: | $3.36B |
| Return on Equity: | 5.45% |
| Return on Assets: | 2.55% |
Labcorp Holdings Earnings Forecast
Key Labcorp Holdings Financial Ratios
- The Gross Profit Margin over the past 35 years for LH is 27.67%.
- The Selling, General & Administrative Expenses for LH have been equal to 16.62% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 47.75% of Operating Income.
- The Net Earning history of LH is 3.44% of Total Revenues.
- Per Share Earnings over the last 36 years have been positive in 23 years.
Labcorp Holdings Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Health Care Providers & Services |
| Sector: | Health Care |
| Current Symbol: | LH |
| CUSIP: | 50540R |
| Website: | labcorp.com |
Debt
| Debt-to-Equity Ratio: | 0.83 |
|---|---|
| Current Ratio: | 1.44 |
| Quick Ratio: | 1.1 |
Price-to-Earnings
| Trailing P/E Ratio: | 50.03 |
|---|---|
| Forward P/E Ratio: | 14.96 |
LH Technical Analysis vs Fundamental Analysis
Sell
42
Labcorp Holdings (LH)
is a Sell
Is Labcorp Holdings a Buy or a Sell?
-
Labcorp Holdings stock is rated a Sell
The current Labcorp Holdings [LH] share price is $237.85. The Score for LH is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.